类风湿关节炎中无药物持续缓解或自然病程的自发缓解？一个未解决的问题：对阿杰加诺娃文章的评论 - Suppr

Suppr

超能文献

Drug-free sustained remission or spontaneous remission by natural history in rheumatoid arthritis? An unsolved question: comment on the article of Ajeganova .

作者信息

Zeidler Henning

出版信息

Ann Rheum Dis. 2017 Jul;76(7):e16. doi: 10.1136/annrheumdis-2016-210887. Epub 2016 Dec 22.

DOI:10.1136/annrheumdis-2016-210887

PMID:28007758

Abstract

摘要

相似文献

Drug-free sustained remission or spontaneous remission by natural history in rheumatoid arthritis? An unsolved question: comment on the article of Ajeganova .类风湿关节炎中无药物持续缓解或自然病程的自发缓解？一个未解决的问题：对阿杰加诺娃文章的评论

Ann Rheum Dis. 2017 Jul;76(7):e16. doi: 10.1136/annrheumdis-2016-210887. Epub 2016 Dec 22.

Does the presence of magnetic resonance imaging-detected osteitis at diagnosis with rheumatoid arthritis lower the risk for achieving disease-modifying antirheumatic drug-free sustained remission: results of a longitudinal study.在类风湿关节炎诊断时存在磁共振成像检测到的骨炎是否会降低达到疾病修饰抗风湿药物无持续缓解的风险：一项纵向研究的结果。

Arthritis Res Ther. 2018 Apr 10;20(1):68. doi: 10.1186/s13075-018-1553-8.

Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.类风湿关节炎中持续停用改善病情抗风湿药缓解的患病率及预测因素：来自两个大型早期关节炎队列的结果

Arthritis Rheum. 2009 Aug;60(8):2262-71. doi: 10.1002/art.24661.

Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation? Comment on article by Boeters DM et al.

Arthritis Res Ther. 2020 Jan 31;22(1):17. doi: 10.1186/s13075-020-2106-5.

Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms.类风湿关节炎的疾病缓解药物停药后持续缓解：随着疾病症状的消退，越来越有可能实现这一目标。

Ann Rheum Dis. 2016 May;75(5):867-73. doi: 10.1136/annrheumdis-2014-207080. Epub 2015 May 13.

Response to: 'Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka ' by Berkhout .对Berkhout对Tanaka的《类风湿关节炎患者缓解后采用递增剂量策略持续停用英夫利昔单抗：RRRR研究，一项随机对照试验》的评论的回应

Ann Rheum Dis. 2021 Nov;80(11):e173. doi: 10.1136/annrheumdis-2019-216593. Epub 2019 Dec 9.

Definition of rheumatoid arthritis remission in clinical practice: comment on the article by Felson et al.临床实践中类风湿关节炎缓解的定义：对费尔森等人文章的评论

Arthritis Rheum. 2011 Nov;63(11):3642; author's reply 3644. doi: 10.1002/art.30554.

Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka .对田中发表的《类风湿关节炎患者缓解后采用递增剂量策略持续停用英夫利昔单抗：RRRR研究，一项随机对照试验》的评论

Ann Rheum Dis. 2021 Nov;80(11):e172. doi: 10.1136/annrheumdis-2019-216557. Epub 2019 Nov 19.

Determinants of reaching drug-free remission in patients with early rheumatoid or undifferentiated arthritis after one year of remission-steered treatment.达到早期类风湿关节炎或未分化关节炎患者缓解后一年无药物缓解的决定因素——缓解导向治疗。

Rheumatology (Oxford). 2015 Aug;54(8):1380-4. doi: 10.1093/rheumatology/keu477. Epub 2015 Feb 15.

Classifying Remission in Rheumatoid Arthritis Treat-to-Target Studies: Comment on the Article by Norvang et al.

Arthritis Rheumatol. 2020 Aug;72(8):1406-1407. doi: 10.1002/art.41269. Epub 2020 Jun 12.

引用本文的文献

Association between rs2476601, rs833070, rs6920220 Polymorphisms and Risk for Rheumatoid Arthritis in Early Undifferentiated Arthritis Patients: A Pilot Study.rs2476601、rs833070、rs6920220 多态性与早期未分化关节炎患者类风湿关节炎风险的关联：一项初步研究。

Medicina (Kaunas). 2023 Oct 13;59(10):1824. doi: 10.3390/medicina59101824.

ACPA-negative and ACPA-positive RA patients achieving disease resolution demonstrate distinct patterns of MRI-detected joint-inflammation.ACPA 阴性和 ACPA 阳性 RA 患者达到疾病缓解时表现出不同的 MRI 检测到的关节炎症模式。

Rheumatology (Oxford). 2022 Dec 23;62(1):124-134. doi: 10.1093/rheumatology/keac294.

Unraveling heterogeneity within ACPA-negative rheumatoid arthritis: the subgroup of patients with a strong clinical and serological response to initiation of DMARD treatment favor disease resolution.解析 ACPA 阴性类风湿关节炎的异质性：在开始 DMARD 治疗时具有强烈临床和血清学反应的患者亚组有利于疾病缓解。

Arthritis Res Ther. 2022 Jan 3;24(1):4. doi: 10.1186/s13075-021-02671-z.

Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis.开始使用改善病情抗风湿药（DMARD）后早期疾病活动评分（DAS）反应增加类风湿关节炎实现无DMARD持续缓解的概率。

Arthritis Res Ther. 2020 Nov 23;22(1):276. doi: 10.1186/s13075-020-02368-9.

DMARD-free remission as novel treatment target in rheumatoid arthritis: A systematic literature review of achievability and sustainability.无 DMARD 缓解作为类风湿关节炎的新型治疗目标：实现和可持续性的系统文献回顾。

RMD Open. 2020 May;6(1). doi: 10.1136/rmdopen-2020-001220.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验